Sina Pharmaceutical Company (DSINA) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DSINA
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 41,558,983 | 19,993,033 | 10,927,676 | 7,942,450 | 3,548,188 | 2,854,817 |
| Cost of operating revenue | -14,713,194 | -7,788,288 | -5,468,461 | -4,046,596 | -1,897,388 | -1,346,085 |
| Gross profit (loss) | 26,845,789 | 12,204,745 | 5,459,215 | 3,895,854 | 1,650,800 | 1,508,732 |
| Selling, general and administrative expenses | -1,806,040 | -1,039,616 | -848,083 | -469,400 | -340,038 | -199,767 |
| Other income | 734,078 | 384,547 | 234,847 | 144,154 | 68,116 | 50,206 |
| Other expenses | -18,554 | -14,177 | -6,196 | -535 | 0 | -432 |
| Operating profit (loss) | 25,755,273 | 11,535,499 | 4,839,783 | 3,570,073 | 1,378,878 | 1,358,739 |
| Finance costs | -718,861 | -195,538 | -317,711 | -355,576 | -197,092 | -187,343 |
| Other non-operating income and expenses | 650,578 | 15,257 | 7,072 | 116,466 | 22,242 | 13,275 |
| Profit (loss) from continuing operations before tax | 25,686,990 | 11,355,218 | 4,529,144 | 3,330,963 | 1,204,028 | 1,184,671 |
| Current year tax | -5,638,808 | -2,554,924 | -1,016,109 | -564,737 | -266,757 | -296,168 |
| Net profit (loss) from continuing operations | 20,048,182 | 8,800,294 | 3,513,035 | 2,766,226 | 937,271 | 888,503 |
| Net profit (loss) | 20,048,182 | 8,800,294 | 3,513,035 | 2,766,226 | 937,271 | 888,503 |
| Basic earnings (loss) per share | 8,364 rials | 3,667 rials | 1,464 rials | 1,153 rials | 1,172 rials | 1,111 rials |
| Net earnings (loss) per share, rials | 8,354 rials | 3,667 rials | 1,464 rials | 1,153 rials | 1,172 rials | - |
| Capital | 2,400,000 | 2,400,000 | 2,400,000 | 2,400,000 | 800,000 | 0 |
Reporting periods
95 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.